This inventor holds 1 USPTO granted patent. Top assignee: Hygea Medical Technology Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Fuliang Luo: Innovator in Cryotherapy Technology
Introduction
Fuliang Luo is a prominent inventor based in Beijing, China. He has made significant contributions to the field of cryotherapy, particularly through his innovative patent that enhances surgical safety and effectiveness. His work is instrumental in advancing medical technology and improving patient outcomes.
Latest Patents
Fuliang Luo holds a patent for a "High and Low Temperature Composite Ablation Surgery System." This system is designed to improve the safety and effectiveness of therapy by utilizing both high and low temperatures. The system comprises a main unit and a cryogenic-thermal ablation probe connected to the main unit. The main unit includes a cold working medium supply system, a hot working medium supply system, and a working medium distribution system. This innovative design allows for the quick rewarming of the therapy area after low-temperature treatment, thereby enhancing the safety, economy, and convenience of surgical procedures.
Career Highlights
Fuliang Luo is associated with Hygea Medical Technology Co., Ltd., where he continues to develop and refine his innovative technologies. His work has garnered attention for its potential to revolutionize surgical practices and improve patient care.
Collaborations
Fuliang Luo collaborates with notable colleagues, including Cuihu Liu and Bowei Chen. Their combined expertise contributes to the advancement of medical technologies and the successful implementation of innovative solutions in the healthcare sector.
Conclusion
Fuliang Luo's contributions to cryotherapy technology exemplify the impact of innovation in the medical field. His patented system not only enhances surgical safety but also paves the way for future advancements in therapeutic techniques.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile